Anoro Ellipta

Anoro Ellipta

umeclidinium + vilanterol

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Predispensed umeclidinium 62.5 mcg, vilanterol (as trifenatate) 25 mcg. Delivered dose of umeclidinium 55 mcg, vilanterol (as trifenatate) 22 mcg
Indications/Uses
Maintenance bronchodilator treatment to relieve symptoms associated w/ COPD.
Dosage/Direction for Use
Contraindications
Hypersensitivity. Severe milk-protein allergy.
Special Precautions
Patients w/ asthma; severe CV disease, narrow-angle glaucoma, urinary retention; convulsive disorder or thyrotoxicosis & patients unusually responsive to β2-adrenergic agonists. Discontinue if paradoxical bronchospasm occurs. Not for the treatment of acute episodes of bronchospasm. If deterioration of COPD during treatment, re-evaluate patients & COPD treatment regimen. Concomitant use w/ other medicines that may cause hypokalemia. Monitor glucose in diabetic patients. Severe hepatic impairment. Pregnancy & lactation. Childn <18 yr.
Adverse Reactions
UTI, sinusitis, nasopharyngitis, pharyngitis, upper resp tract infection; headache; cough, oropharyngeal pain; constipation, dry mouth.
Drug Interactions
Avoid concurrent use of either nonselective or selective β-adrenergic blockers. May inhibit metabolism & increase systemic exposure w/ strong CYP3A4 inhibitors (eg, ketoconazole, clarithromycin, itraconazole, ritonavir, telithromycin). May potentiate adverse reactions w/ known inhaled antimuscarinics & β2-adrenergic agonist. May potentiate possible hypokalaemic effect w/ methylxanthine derivatives, steroids or non-K-sparing diuretics.
ATC Classification
R03AL03 - vilanterol and umeclidinium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Anoro Ellipta inhalation powd 62.5 mcg/25 mcg
Packing/Price
30's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in